Fred Imbert,Yun Li
Futures on the Dow Jones Industrial Average jumped 450 points, or 1.7%. The move implied a 420-point gain at the open. S&P 500 futures climbed 1.3%. Nasdaq-100 futures rose 0.9%.
Moderna’s potential vaccine to prevent Covid-19 produced a “robust” immune response, or neutralizing antibodies, in all 45 patients in its early stage human trial, according to newly released data published Tuesday evening in the peer-reviewed New England Journal of Medicine.
Shares of Moderna surged 15% in premarket trading. Stocks directly tied to an economic reopening jumped following the vaccine news. American Airlines, United Airlines, Royal Caribbean Cruise Lines all popped more than 7% each in premarket trading.
“This should further increase confidence that we are getting a robust immune response, in that there should be greater confidence that this will be protective to a degree in transmission of Covid,” Michael Yee, a managing director at Jefferies, said on CNBC’s “Fast Money.” “This is all along our positive thesis and our view that both Moderna and Pfizer-BioNTech are definitely on a good track to get a vaccine by the end of the year.”
Investors will monitor another batch of corporate earnings results on Tuesday with Goldman Sachs, UnitedHealth, Bank of NY Mellon, U.S. Bancorp and PNC Financial all set to report before the bell.
Earnings from big banks so far have been mixed. JPMorgan Chase reported better-than-expected quarterly results on the back of a massive surge in trading revenue. Wells Fargo suffered a $2.4 billion loss and slashed its dividend to 10 cents per share.
Meanwhile, tensions between the U.S. and China continue to rise. President Donald Trump said Tuesday that he signed legislation to impose sanctions on China in response to its interference with Hong Kong’s autonomy.
—CNBC’s Jesse Pound contributed reporting.